Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 165
Selected: 0
NCT IDTitle
NCT00058929A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension
NCT06911632Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
NCT00060996Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
NCT02663895Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis
NCT00004497Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
NCT05101564Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer
NCT03496623A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
NCT03794583Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
NCT00458042Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction
NCT01353027Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
NCT01557660Inhaled Treprostinil for PAH: Open-label Extension
NCT04341948Treatment of Post-Operative Pain Following Orthopedic Surgery With SPRINT® Peripheral Nerve Stimulation (PNS) System
NCT03016468Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH
NCT04677829Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI)
NCT00848939Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis
NCT03012646Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD
NCT01266265Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
NCT02360345Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly
NCT00439946Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
NCT04827056Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
NCT00963001Effect of Food on the Pharmacokinetics of Oral Treprostinil
NCT04850105A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT00147199Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)
NCT01934582A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
NCT06223009Phase 1 Healthy Volunteer Burn Therapy Study
NCT06814717A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10% Total Body Surface Area Burns
NCT03804944Converting HR+ Breast Cancer Into an Individualized Vaccine
NCT02149095Dose Escalation, MTD, Safety and PK Study of a Single Dose SC Injection of TransCon PEG Treprostinil in Healthy Male Volunteers
NCT01268553Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
NCT05340426Porcine Kidney Xenotransplantation in Patients With End-Stage Kidney Disease
NCT073912155G-PEARL: Paxalisib in Malignant Brain Tumours
NCT01560637An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
NCT00067041Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft
NCT01042158A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
NCT03037580Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
NCT02882126An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension
NCT06477640Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension
NCT03888365Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH
NCT03047369The Myelin Disorders Biorepository Project
NCT06878560Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
NCT03833323Implantable System for Remodulin Post-Approval Study
NCT02630316Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
NCT05564637A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
NCT00969722A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients
NCT06580444Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study
NCT01043627Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
NCT00643604Rapid Switch From Flolan to Remodulin in the Outpatient Clinic
NCT00911248PTC299 for Treatment of Neurofibromatosis Type 2
NCT02074449Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)
NCT02279745Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension